Pinnacle Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,838
Closed -$486K 103
2022
Q3
$486K Buy
6,838
+193
+3% +$14K 0.43% 50
2022
Q2
$512K Buy
6,645
+57
+0.9% +$4.34K 0.43% 52
2022
Q1
$481K Hold
6,588
0.36% 63
2021
Q4
$411K Hold
6,588
0.3% 77
2021
Q3
$390K Hold
6,588
0.29% 80
2021
Q2
$440K Buy
+6,588
New +$430K 0.32% 77

Other funds holding BMY

Pinnacle Wealth Management Group's BMY Position: Q4 2022 in Review

Pinnacle Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 6,838 shares — an estimated $486K sold.

Pinnacle Wealth Management Group first reported a position in BMY in Q2 2021 and held it in 6 quarters. The position peaked at $512K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Pinnacle Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Wealth Management Group sold 6,838 Bristol-Myers Squibb shares in Q4 2022, an estimated $486K.
  • Pinnacle Wealth Management Group first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 6 quarters.
  • Pinnacle Wealth Management Group's Bristol-Myers Squibb position peaked at $512K in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Pinnacle Wealth Management Group's 13F filing for Q4 2022, filed 9 Jan 2023.